PFAS restriction proposal Statement from SEW-EURODRIVE SEW-EURODRIVE GmbH & Co KG 1.

IMPACT OF FIFLOW BB 61 ON REDNESS AND WHITENING FIFLOW products are fully fluorinated perfluorocarbons, which have a high capacity to carry gases, notably Oxygen, Nitrogen and Carbon Dioxide.

5.

FINAL REPORT Hydrothermal Technologies for On-Site Destruction of Site Investigation Wastes Contaminated with Per- and Polyfluoroalkyl Substances (PFAS) SERDP Project ER18-1501 SEPTEMBER 2020 Timothy J.

Study on International Trends Regarding PFAS FY2020 Summary of This Study Since PFOS and PFOA, which belong to PFAS, were recognized as toxic and persistent in the environment, they are subject to the regulations under the Stockholm Convention on persistent organic pollutants, and Japan has been implementing or considering measures including their prohibition of manufacture and import under the Act on the Evaluation of Chemical Substances and Regulation of Their Manufacture, etc.

Draft agenda for PFAS-RESTRICTION WEBEX Meeting between DE, DK, NL, NO, SE CA and ECHA and COM 22 February, 9:00 - 13:00 (CET) Login details: See below Point 1 - Opening and adoption of the agenda (9:00-9:10 am) Point 2 - Minutes and action points (9:10 - 9:20 am) 2020-02-12_PFAS RESTR-13 Minutes and APs_Draft of FINAL.docx 2020-02-12_Continued list of APs and their status.docx Point 3 - Status of COM/ECHA restriction on firefighting foams (9:20- 9:30 am) Point 4 - Restriction dossier strategy, overarching discussion (9:30 - 10:15) Point 5 - Status update WP7 and Essential Use (10:15 - 10:25 am) Point 6 - Status update WP1 (10:25 - 10:35 am) Point 7 - Status update WP2 (10:35 - 10:50 am) Point 8 - Status update WP3 (10:50 - 11:05 am) Break 11:05 - 11:30 am Point 9 - Status update WP5 (10:50 - 11:00 am) Point 10 - Status update WP6 (11:00 - 11:10 am) Point 11 - Status update WP4 (11:30 - 12:00 am) o Point 12 - Action points, next steps & meetings (12:00 - 12:10 am) WebEx Details BAuA Webkonferenz Ausgerichtet von BAuA Webkonferenz 66 https://baua.my.webex.com/baua.my/i.php?

dd Dec 20 WP WP0 DE/NL Responsible WP1 DE/NL Activities Coordination Preparation of Call for Evidence (including questionnaire and information document) in agreement between MS Call for Evidence (all MS and ECHA with news alerts and websites of all MS with Link to Helpdesk webpage) Preparation of Restriction option analysis document (all MS) RIME+ Dortmund 1st draft of restriction option analysis document (all MS) 2nd draft of restriction option analysis document (all MS) Finalisation of document, i.e. clarification of restriction options and scope (all MS) Restriction option analysis document to be uploaded on CIRCA (DE/ NL CA) RMOA-Conclusion, PACT-Update WP2 Drafting discussion paper NL Wordt vragenlijst + aanvulling 1e discussion paper WP3 DE/DK DE/DK WP4 NL/DE Verwerken commentaren van NO, SE, DE, I&W en RIVM deskundigen Coordination and alignment Pre-phase for environmental and human health hazard assessment --> Overview of relevant hazards (besides persistence) and generation of draft lists of substances for assessment Assessment phase --> Draft text for restriction proposal WP5 NO WP6 SE/DE Overview analytical methods (ch E7) Overview human and environmental monitoring data Working plan Design template for collection of monitoring date Presentation of slide WP6 at RiME Meeting wieh NCSU Collect monitoring data - ENV Collect monitoring data - HUM RiME FEB-2021 WP7 Scoping essential use NL Scoping impact assessment Baseline and restriction scenario(s) Economic impact assessment Environmental impact assessment Health impact assessment Assessment of other impacts Proportionality analysis Monthly meetings starts 2nd version questionnaire Draft of information document (DE/NL CA) Commenting round (all MS) Revision and draft of 3rd version of questionnaire and information document for WebEx (DE/NL CA) Detailed discussion of questionnaire and information document (all MS) Webex Final version (DE/ NL CA) Notification into PACT (DE/ NL CA) Discussion of responses received so far, data (all MS) Webex Decision on meetings with industry (all MS) DDiescciusisosnioonnowf rheiscthrircetisotrnicstcioonpeopantidonospstihoonusld(ablleMpSre) sWenetbeedx and discussed in RiME+ (all MS) Meetings with stakeholders and industry Presentation on RMOA for RiME May 2020 Contributions of first drafts of document parts according to lead in work packages and sub-work packages (all MS) Merge of contributions, redrafting (DE/ NL CA) Redrafting by all MS Merge of contributions, redrafting (DE/ NL CA) 31-Mar-20 4-May-20 August/September 2020 20/21 October 2020 25-Sep-20 5-Oct-20 19-Oct-20 Last redrafting by all MS Finalisation (DE/ NL CA) Commenting (by all other MS not part of group) Consideration of comments/if needed redrafting of document (DE/ NL CA in agreement with group) Webex meeting for initial discussing based on broad definition (NL, DE, SE, DK, NO, ECHA, COM) 1st discussion paper prepared by NL Face-to-face meeting (NL, DE, SE, DK, NO, ECHA, COM) based on discussion paper 2nd discussion paper prepared by NL (before RiME+) 26-Oct-20 10-Nov-20 23 - 27 November 2020 1-Dec-20 4-Jan-21 Discussion during RiME+ meeting Final discussion paper prepared by NL 2021 - TO BE PREPARED Kick-off meeting Joint HH/ENV progress meetings HH subgroup meetings ENV subgroup meetings Start up, Develop generic information basis for all sub-uses, structure of the sub-use reports (by WP7) - DONE Kick-off meeting (Discussion of content of each sub-use to avoid overlaps and discussion of revision of list of sub-uses and discussion of ETH Zrich work) - DONE 1 May 2020 1 Nov. 2020 Start up sub uses, Project plan fine tuning for sub-uses (and if needed tendering for consultants) Progress meeting after CfE is closed to check sub-uses, decide on stakeholder meetings (i.e. via mail) Stakeholder Meetings per sub-use: Follow up on information from CfE and to address knowledge gaps Sub-use studies (including gap analysis) Progress meeting Progress meeting Final reports consultants (& feedback to WP2) Integration of information (including gap analysis) Additional studies (i.e. membranes, processing aids?)

Lab Na L 1538 NOTICE SBRTC-2016-0335-2 1.

The Global Asthma Report 2022 Global Asthma Network 1 in 10 children have asthma symptoms Half have inadequately controlled symptoms Many have no access to essential asthma medicines Copyright 2022 The Global Asthma Network All rights reserved.

Request for the exemption; the use of PVdF in lithium-ion batteries (LIB).

Request for derogation on the use of PTFE as anti-drip agent in thin wall flame retardant polycarbonate compounds Table of Contents Executive Summary .............................................................................................................. 2 1.

June 8,2023 JAPAN CONSTRUCTION EQUIPMENT MANUFACTURERS ASSOCIATION 2F, Kikaishinkokaikan 3-5-8 Shibakoen, Minato-ku, Tokyo 105-0011, Japan TEL(03)5405-2288/FAX(03)5405-2280 Written comments on the Annex XV Restriction Report Restrictions on the manufacture, market placement, and use of PFAS, jointly proposed by Germany, the Netherlands, Sweden, Norway, and Denmark, have been published in the Annex XV Restriction Report.

41-C INDUSTRIES Siedziba - ul.